SGB Invests in QCi Labs With Plans to Build a Super Lab
In October 2021, Supergalactic Brands announced its investment in QCi Labs — not just a capital infusion, but the beginning of a deliberate infrastructure build. The goal: create what the team called a Super Lab — a GMP-certified extraction and analytics facility capable of manufacturing at the quality level and scale that SGB's portfolio ambitions required.
The investment marked the moment SGB stopped being a brand company and started being a vertically integrated operator. That distinction would define everything that followed.
Why Vertical Manufacturing
Most cannabis brands are, at their core, marketing operations. They outsource formulation, outsource extraction, outsource manufacturing. That works until it doesn't — until a supplier relationship breaks, until quality control fails, until a competitor buys exclusive access to your formula. SGB's investment in QCi Labs was a deliberate rejection of that model.
Controlling the lab means controlling the product. Controlling the product means controlling the brand. There's no other way to build something defensible.
What the Super Lab Became
The QCi Labs facility in Colorado is today GMP-certified and Safe Harbor certified — a manufacturing arm capable of producing Sano Gardens' premium concentrates, Orchard's THC infusions, SUM Microdose's sublingual formulations, and the nano-emulsification science developed by Teeny Tiny Science. The Super Lab vision became reality. The portfolio is built on top of it.